Phosphorylation/dephosphorylation of human SULT4A1: Role of Erk1 and PP2A

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1813, Issue 1, 2011, Pages 231-237

  Mitchell, Deanne J ^a   Butcher, Neville J ^a   Minchin, Rodney F ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

ERK1; Phosphorylation; PP2A; Sulfotransferase

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE 3; PEPTIDYLPROLYL ISOMERASE PIN1; PHOSPHOPROTEIN PHOSPHATASE 2A; SULFOTRANSFERASE; SULT4A1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; ENZYME DEGRADATION; ENZYME PHOSPHORYLATION; ENZYME STABILITY; FEMALE; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEPHOSPHORYLATION; PROTEIN EXPRESSION; RAT;

ANIMALS; BLOTTING, WESTERN; HELA CELLS; HUMANS; IMMUNOPRECIPITATION; MITOGEN-ACTIVATED PROTEIN KINASE 3; PC12 CELLS; PEPTIDYLPROLYL ISOMERASE; PHOSPHORYLATION; PROTEIN BINDING; PROTEIN PHOSPHATASE 2; PROTEIN PROCESSING, POST-TRANSLATIONAL; RATS; SULFOTRANSFERASES; THREONINE; TWO-HYBRID SYSTEM TECHNIQUES;

EID: 78650743362     PISSN: 01674889     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2010.09.011     Document Type: Article

References (44)

1. Minchin R.F., Lewis A., Mitchell D., Kadlubar F.F., McManus M.E. Sulfotransferase 4A1. Int. J. Biochem. Cell Biol. 2007.
2. Brennan M.D., Condra J. Transmission disequilibrium suggests a role for the sulfotransferase-4A1 gene in schizophrenia. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2005, 139:69-72.
3. Condra J.A., Neibergs H., Wei W., Brennan M.D. Evidence for two schizophrenia susceptibility genes on chromosome 22q13. Psychiatr. Genet. 2007, 17:292-298.
4. Modena P., Lualdi E., Facchinetti F., Veltman J., Reid J.F., Minardi S., Janssen I., Giangaspero F., Forni M., Finocchiaro G., Genitori L., Giordano F., Riccardi R., Schoenmakers E.F., Massimino M., Sozzi G. Identification of tumor-specific molecular signatures in intracranial ependymoma and association with clinical characteristics. J. Clin. Oncol. 2006, 24:5223-5233.
5. Kiba T., Kintaka Y., Suzuki Y., Nakata E., Ishigaki Y., Inoue S. Ventromedial hypothalamic lesions change the expression of neuron-related genes and immune-related genes in rat liver. Neurosci. Lett. 2009, 455:14-16.
6. Yu D., Cook M.C., Shin D.M., Silva D.G., Marshall J., Toellner K.M., Havran W.L., Caroni P., Cooke M.P., Morse H.C., MacLennan I.C., Goodnow C.C., Vinuesa C.G. Axon growth and guidance genes identify T-dependent germinal centre B cells. Immunol. Cell Biol. 2008, 86:3-14.
7. Lewis A.G., Minchin R.F. Lack of exonic sulfotransferase 4A1 mutations in controls and schizophrenia cases. Psychiatr. Genet. 2009, 19:53-55.
8. Hildebrandt M.A., Carrington D.P., Thomae B.A., Eckloff B.W., Schaid D.J., Yee V.C., Weinshilboum R.M., Wieben E.D. Genetic diversity and function in the human cytosolic sulfotransferases. Pharmacogenomics J. 2007, 7:133-143.
9. Mitchell D.J., Minchin R.F. Cytosolic Aryl sulfotransferase 4A1 interacts with the peptidyl prolyl cis-trans isomerase Pin1. Mol. Pharmacol. 2009, 76:388-395.
10. Lorenz K., Schmitt J.P., Schmitteckert E.M., Lohse M.J. A new type of ERK1/2 autophosphorylation causes cardiac hypertrophy. Nat. Med. 2009, 15:75-83.
11. Bonnet F., Vigneron M., Bensaude O., Dubois M.F. Transcription-independent phosphorylation of the RNA polymerase II C-terminal domain (CTD) involves ERK kinases (MEK1/2). Nucleic Acids Res. 1999, 27:4399-4404.
12. Ewings K.E., Hadfield-Moorhouse K., Wiggins C.M., Wickenden J.A., Balmanno K., Gilley R., Degenhardt K., White E., Cook S.J. ERK1/2-dependent phosphorylation of BimEL promotes its rapid dissociation from Mcl-1 and Bcl-xL. EMBO J. 2007, 26:2856-2867.
13. Okabe H., Lee S.H., Phuchareon J., Albertson D.G., McCormick F., Tetsu O. A critical role for FBXW8 and MAPK in cyclin D1 degradation and cancer cell proliferation. PLoS ONE 2006, 1:e128.
14. Wang Y.N., Chen Y.J., Chang W.C. Activation of extracellular signal-regulated kinase signaling by epidermal growth factor mediates c-Jun activation and p300 recruitment in keratin 16 gene expression. Mol. Pharmacol. 2006, 69:85-98.
15. Wang R., He G., Nelman-Gonzalez M., Ashorn C.L., Gallick G.E., Stukenberg P.T., Kirschner M.W., Kuang J. Regulation of Cdc25C by ERK-MAP kinases during the G2/M transition. Cell 2007, 128:1119-1132.
16. Wera S., Hemmings B.A. Serine/threonine protein phosphatases. Biochem. J. 1995, 311(Pt 1):17-29.
17. Jones S.W., Erikson E., Blenis J., Maller J.L., Erikson R.L. A Xenopus ribosomal protein S6 kinase has two apparent kinase domains that are each similar to distinct protein kinases. Proc. Natl Acad. Sci. USA 1988, 85:3377-3381.
18. Sturgill T.W., Ray L.B., Erikson E., Maller J.L. Insulin-stimulated MAP-2 kinase phosphorylates and activates ribosomal protein S6 kinase II. Nature 1988, 334:715-718.
19. Deak M., Clifton A.D., Lucocq L.M., Alessi D.R. Mitogen- and stress-activated protein kinase-1 (MSK1) is directly activated by MAPK and SAPK2/p38, and may mediate activation of CREB. EMBO J. 1998, 17:4426-4441.
20. Fukunaga R., Hunter T. MNK1, a new MAP kinase-activated protein kinase, isolated by a novel expression screening method for identifying protein kinase substrates. EMBO J. 1997, 16:1921-1933.
21. Waskiewicz A.J., Flynn A., Proud C.G., Cooper J.A. Mitogen-activated protein kinases activate the serine/threonine kinases Mnk1 and Mnk2. EMBO J. 1997, 16:1909-1920.
22. Trinidad J.C., Thalhammer A., Specht C.G., Lynn A.J., Baker P.R., Schoepfer R., Burlingame A.L. Quantitative analysis of synaptic phosphorylation and protein expression. Mol. Cell. Proteomics 2008, 7:684-696.
23. Monje P., Hernandez-Losa J., Lyons R.J., Castellone M.D., Gutkind J.S. Regulation of the transcriptional activity of c-Fos by ERK. A novel role for the prolyl isomerase PIN1. J. Biol. Chem. 2005, 280:35081-35084.
24. Zheng Y., Xia Y., Hawke D., Halle M., Tremblay M.L., Gao X., Zhou X.Z., Aldape K., Cobb M.H., Xie K., He J., Lu Z. FAK phosphorylation by ERK primes ras-induced tyrosine dephosphorylation of FAK mediated by PIN1 and PTP-PEST. Mol. Cell 2009, 35:11-25.
25. Bogoyevitch M.A., Court N.W. Counting on mitogen-activated protein kinases-ERKs 3, 4, 5, 6, 7 and 8. Cell. Signal. 2004, 16:1345-1354.
26. Boulton T.G., Nye S.H., Robbins D.J., Ip N.Y., Radziejewska E., Morgenbesser S.D., DePinho R.A., Panayotatos N., Cobb M.H., Yancopoulos G.D. ERKs: a family of protein-serine/threonine kinases that are activated and tyrosine phosphorylated in response to insulin and NGF. Cell 1991, 65:663-675.
27. Chang L., Karin M. Mammalian MAP kinase signalling cascades. Nature 2001, 410:37-40.
28. English J., Pearson G., Wilsbacher J., Swantek J., Karandikar M., Xu S., Cobb M.H. New insights into the control of MAP kinase pathways. Exp. Cell Res. 1999, 253:255-270.
29. Gonzalez F.A., Raden D.L., Davis R.J. Identification of substrate recognition determinants for human ERK1 and ERK2 protein kinases. J. Biol. Chem. 1991, 266:22159-22163.
30. Chen J., Rusnak M., Luedtke R.R., Sidhu A. D1 dopamine receptor mediates dopamine-induced cytotoxicity via the ERK signal cascade. J. Biol. Chem. 2004, 279:39317-39330.
31. Valjent E., Corvol J.C., Pages C., Besson M.J., Maldonado R., Caboche J. Involvement of the extracellular signal-regulated kinase cascade for cocaine-rewarding properties. J. Neurosci. 2000, 20:8701-8709.
32. Valjent E., Pascoli V., Svenningsson P., Paul S., Enslen H., Corvol J.C., Stipanovich A., Caboche J., Lombroso P.J., Nairn A.C., Greengard P., Herve D., Girault J.A. Regulation of a protein phosphatase cascade allows convergent dopamine and glutamate signals to activate ERK in the striatum. Proc. Natl Acad. Sci. USA 2005, 102:491-496.
33. Si J., Mei L. ERK MAP kinase activation is required for acetylcholine receptor inducing activity-induced increase in all five acetylcholine receptor subunit mRNAs as well as synapse-specific expression of acetylcholine receptor epsilon-transgene. Brain Res. Mol. Brain Res. 1999, 67:18-27.
34. Cohen P., Klumpp S., Schelling D.L. An improved procedure for identifying and quantitating protein phosphatases in mammalian tissues. FEBS Lett. 1989, 250:596-600.
35. Ingebritsen T.S., Stewart A.A., Cohen P. The protein phosphatases involved in cellular regulation. 6. Measurement of type-1 and type-2 protein phosphatases in extracts of mammalian tissues; an assessment of their physiological roles. Eur. J. Biochem. 1983, 132:297-307.
36. Mayer R.E., Hendrix P., Cron P., Matthies R., Stone S.R., Goris J., Merlevede W., Hofsteenge J., Hemmings B.A. Structure of the 55-kDa regulatory subunit of protein phosphatase 2A: evidence for a neuronal-specific isoform. Biochemistry 1991, 30:3589-3597.
37. Virshup D.M. Protein phosphatase 2A: a panoply of enzymes. Curr. Opin. Cell Biol. 2000, 12:180-185.
38. Janssens V., Goris J. Protein phosphatase 2A: a highly regulated family of serine/threonine phosphatases implicated in cell growth and signalling. Biochem. J. 2001, 353:417-439.
39. Csortos C., Zolnierowicz S., Bako E., Durbin S.D., DePaoli-Roach A.A. High complexity in the expression of the B' subunit of protein phosphatase 2A0. Evidence for the existence of at least seven novel isoforms. J. Biol. Chem. 1996, 271:2578-2588.
40. McCright B., Rivers A.M., Audlin S., Virshup D.M. The B56 family of protein phosphatase 2A (PP2A) regulatory subunits encodes differentiation-induced phosphoproteins that target PP2A to both nucleus and cytoplasm. J. Biol. Chem. 1996, 271:22081-22089.
41. McCright B., Virshup D.M. Identification of a new family of protein phosphatase 2A regulatory subunits. J. Biol. Chem. 1995, 270:26123-26128.
42. Schmidt K., Kins S., Schild A., Nitsch R.M., Hemmings B.A., Gotz J. Diversity, developmental regulation and distribution of murine PR55/B subunits of protein phosphatase 2A. Eur. J. Neurosci. 2002, 16:2039-2048.
43. Strack S., Chang D., Zaucha J.A., Colbran R.J., Wadzinski B.E. Cloning and characterization of B delta, a novel regulatory subunit of protein phosphatase 2A. FEBS Lett. 1999, 460:462-466.
44. Yeh E., Cunningham M., Arnold H., Chasse D., Monteith T., Ivaldi G., Hahn W.C., Stukenberg P.T., Shenolikar S., Uchida T., Counter C.M., Nevins J.R., Means A.R., Sears R. A signalling pathway controlling c-Myc degradation that impacts oncogenic transformation of human cells. Nat. Cell Biol. 2004, 6:308-318.